Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vir Biotechnology Inc (NQ: VIR ) 10.23 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vir Biotechnology Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Planet Labs PBC, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session September 08, 2023 U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Stocks That Hit 52-Week Lows On Thursday September 07, 2023 On Thursday, 283 companies set new 52-week lows. Via Benzinga Is Vir Biotechnology Stock a Buy? August 11, 2023 The biotech is out to prove that it isn't just a "pandemic stock." Via The Motley Fool Stocks That Hit 52-Week Lows On Tuesday September 05, 2023 On Tuesday morning, 164 companies achieved new lows for the year. Via Benzinga Earnings Scheduled For August 3, 2023 August 03, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. Via Benzinga Microsoft, Snap, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session July 26, 2023 U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Snap Inc. (NYSE: SNAP) shares tumbled 18.6% to $10.18 in... Via Benzinga Where Vir Biotechnology Stands With Analysts July 21, 2023 Via Benzinga Crude Oil Edges Higher; American Airlines Raises Profit Outlook July 20, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling more than 250 points on Thursday. The Dow traded up 0.60% to 35,270.02 while the NASDAQ fell 1.89% to 14,086.02.... Via Benzinga Why Vir Biotechnology Stock Is Plunging Today? July 20, 2023 Vir Biotechnology Inc (NASDAQ: VIR) shares are tumbling after the company released data from the Phase 2 PENINSULA evaluating VIR-2482 to prevent Via Benzinga What 8 Analyst Ratings Have To Say About Vir Biotechnology April 04, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Thursday July 20, 2023 During Thursday's session, 40 stocks hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 20, 2023 Via Benzinga Dow On Track For 9 Straight After Johnson & Johnson Earnings July 20, 2023 The Dow Jones Industrial Average is looking to extend its win streak, last seen up 250 points as it paces for its ninth consecutive win. Via Talk Markets Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings July 20, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite declining over 1% on Thursday. The Dow traded up 0.87% to 35,365.00 while the NASDAQ fell 1.11% to 14,198.86. The S&P 500,... Via Benzinga Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 20, 2023 Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. Via Benzinga Why Shares of Vir Biotechnology Are Plunging Thursday July 20, 2023 The company had disappointing trial news for one of its lead therapies. Via The Motley Fool Nasdaq Down 50 Points; Tesla Earnings Beat Expectations July 20, 2023 U.S. stocks traded mixed this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.40% to 35,202.41 while the NASDAQ fell 0.35% to... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 20, 2023 Via Benzinga Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics June 26, 2023 As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other... Via Benzinga WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake May 19, 2023 An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the Via Benzinga 7 Top-Rated Stocks That Will Boost Your Portfolio in 2023 May 10, 2023 For those seeking to rise above the muck in a big way, these top-rated stocks to buy might accomplish just that. Via InvestorPlace WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns May 08, 2023 The World Health Organization ended the global emergency Via Benzinga The 7 Best Bargain Stocks to Buy for May 2023 May 04, 2023 With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly. Via InvestorPlace Why Shares of Keros Therapeutics Jumped This Week April 21, 2023 The company appointed a new director and an analyst reiterated his position on the stock. Via The Motley Fool Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments April 11, 2023 The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a... Via Benzinga 7 Thrilling Biotech Stocks for Aggressive Investors to Buy April 05, 2023 Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. Via InvestorPlace Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information March 21, 2023 Via Benzinga Biotech Stocks And The SVB Collapse — Here's What We Know March 14, 2023 The collapse of SVB will have a big impact on early-stage, venture-backed companies. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023 March 06, 2023 Via Benzinga Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results March 06, 2023 Vir Biotechnology, Inc. (NASDAQ: VIR) reported worse-than-expected Q4 results. Vir Biotechnology posted a Q4 loss of $0.76 per share, versus market expectations of $0.39 per share. The company’s... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.